Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 224,951,226 papers from all fields of science
Search
Sign In
Create Free Account
squamosamide
Known as:
Benzeneacetamide, 4-hydroxy-alpha-((4-hydroxy-3-methoxyphenyl)methylene)-N-(2-(4-hydroxyphenyl)ethyl)-3,5-dimethoxy-, (E)-
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (2)
Benzeneacetamides
Phenols
Narrower (1)
FLZ compound
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
FLZ attenuates learning and memory deficits via suppressing neuroinflammation induced by LPS in mice
Liang-yu Wu
,
Xiu-Qi Bao
,
Hong-yan Pang
,
Hua Sun
,
Dan Zhang
Journal of Asian natural products research
2015
Corpus ID: 29717080
Alzheimer's disease (AD) is the most common neurodegenerative disorder in which neuroinflammation plays an important role. FLZ is…
Expand
2015
2015
Squamosamide Derivative FLZ Protects Pancreatic β-Cells from Glucotoxicity by Stimulating Akt-FOXO1 Pathway
Xiangchen Kong
,
Longmei Zhang
,
X. Hua
,
Xiaosong Ma
Journal of Diabetes Research
2015
Corpus ID: 16540917
Chronic hyperglycemia increases apoptosis and reduces glucose-stimulated insulin secretion. Although protective agents have been…
Expand
2013
2013
[Therapeutic effect of a natural squamosamide derivative FLZ on Parkinson's disease model mice induced by LPS plus MPTP].
Ling-hong Yu
,
Huai-ling Wei
,
Xiu-Qi Bao
,
Dan Zhang
,
Hua Sun
Yao xue xue bao = Acta pharmaceutica Sinica
2013
Corpus ID: 1429695
The aim of this study is to investigate the protective effect of N-[2-(4-hydroxyphenyl)ethyl]-2-(2, 5-dimethoxyphenyl)-3-(3…
Expand
2011
2011
Anti-proliferative effects of the novel squamosamide derivative (FLZ) on HepG2 human hepatoma cells by regulating the cell cycle-related proteins are associated with decreased Ca(2+)/ROS levels.
Yong Qin
,
Xiang Pan
,
Tian Tang
,
Liang Zhou
,
Xing-guo Gong
Chemico-Biological Interactions
2011
Corpus ID: 6546184
2009
2009
A natural squamosamide derivative FLZ reduces amyloid-beta production by increasing non-amyloidogenic AbetaPP processing.
Yan Hou
,
Young-beob Yu
,
Geng-tao Liu
,
Yuan Luo
Journal of Alzheimer's Disease
2009
Corpus ID: 30275081
Substantial evidence supports a central role of Abeta in the pathogenesis of Alzheimer's disease (AD). We have demonstrated that…
Expand
2008
2008
Novel squamosamide derivative (compound FLZ) attenuates Aβ25–35-induced toxicity in SH-SY5Y cells
F. Fang
,
Geng-tao Liu
Acta Pharmacologica Sinica
2008
Corpus ID: 20911448
AbstractAim:The aim of the present study was to investigate the protective effect of compound N-[2-(4-hydroxy-phenyl)-ethyl]-2-(2…
Expand
2006
2006
Protective effects of compound FLZ on β-amyloid peptide-(25–35)-induced mouse hippocampal injury and learning and memory impairment
F. Fang
,
Geng-tao Liu
Acta Pharmacologica Sinica
2006
Corpus ID: 22144576
AbstractAim:To study the protective effects of compound FLZ, a novel synthetic analogue of natural squamosamide, on learning and…
Expand
1993
1993
[Studies on total synthesis of squamosamide].
X. Ji
,
X. Liang
Yao xue xue bao = Acta pharmaceutica Sinica
1993
Corpus ID: 8804706
A new natural compound squamosamide isolated from Annona squamosa, was synthesized. This compound was characterized by 1H, 13CNMR…
Expand
1993
1993
Studies on total synthesis of squamosamide
Jia Xs
,
Liang Xt
1993
Corpus ID: 100301331
A new natural compound squamosamide isolated from Annona squamosa,was synthesized. This compound was characterized by ~1H, ~(13…
Expand
1992
1992
[Studies on the chemical constituents of Annona squamosa].
X. Yang
,
L. Xu
,
N. Sun
,
S. C. Wang
,
Zheng
Yao xue xue bao = Acta pharmaceutica Sinica
1992
Corpus ID: 40779925
Twelve compounds were isolated from Annona squamosa. Their structures were identified as liriodenine (AS-1), moupinamide (AS-2…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE